Ali Arbab


Ali Arbab


Academic Appointment(s)

Medical College of Georgia
Department of Biochemistry and Molecular Biology

Medical College of Georgia
Department of Georgia Cancer Center

The Graduate School


I have 30 years of experience in imaging science, involving MRI, SPECT, CT, ultrasound, and optical imaging modalities. My laboratory is working on to target tumor microenvironment of GBM and breast cancers using different agents and modalities

  • (706) 721-8909
  • (706) 434-6406
  • CN3315


  • Ph.D., Medical Scientist. Yamanashi Medical University, 1998

  • MD, Medicine University of Dhaka, 1988

Awards & Honors

  • Grant Reviewer The National Institutes of Health, 2020

  • Grant reviewer California Institute of Regenerative Medicine, 2017

  • Travel Award Radiological Society of North America (RSNA), 2008

  • Fellows Award for Research Excellence (FARE) The National Institutes of Health, 2003

  • Asia-Oceania Young Investigator’s Award Japanese Society of Nuclear Medicine, 1999

Courses Taught Most Recent Academic Year

  • BCMB 8201

    Cur Topics & Tech in MB
  • BIOM 8215

    Fundamentals of Oncology I
  • BCMB 9210

    Investigation of Problem
  • BCMB 9010

    Seminar in BMB
  • BCMB 8340

    Elements of Scientific Pres


Selected Recent Publications

  • Oncoprotein GT198 vaccination delays tumor growth in MMTV-PyMT mice., 2020
    Journal Article, Academic Journal
  • CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint., 2020
    Journal Article, Academic Journal
  • Differential in vivo biodistribution of 131I-labeled exosomes from diverse cellular origins and its implication for theranostic application., 2019
    Journal Article, Academic Journal
  • CYP4A/20-HETE regulates ischemia-induced neovascularization via its actions on endothelial progenitor and preexisting endothelial cells., 2019
    Journal Article, Academic Journal
  • Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model., 2019
    Journal Article, Academic Journal

Research Interests

> Generation of engineered exosomes to initiate ADCC of targeted cells by NK cells.
> Ultrasound mediated delivery of exosomes
> Understanding the mechanisms of resistance to antiangiogenic treatment in solid tumors.
> Targeting arachidonic acid metabolites for the treatment of solid tumors.
>Tumor cell-secreted exosomes in modulating tumor microenvironment and niche for distal metastasis.
> Generation of tissue-specific MRI and SPECT contrast agents and drug delivery systems (nanoparticles).

University Service

  • Mock Study Section 2019 - 2020

    Role: Administrative Assignment, Other
  • Steering Committee 2019 - 2020

    Role: Committee Member

Professional Service

  • - 2020

    Role: Editorial Review Board Member
  • - 2020

    Role: Reviewer